Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer - Schreiber, Anna R.; Smoots, Stephen G.; Jackson, Marilyn M.; Bagby, Stacey M.; Dus, Evan D.; Dominguez, Adrian T. A.; Binns, Cameron A.; Pitts, Todd M.; Diamond, Jennifer R. (Frontiers in Oncology, 2025)